Ondansetron Tablet, Orally Disintegrating
Product Images NDC 65862-390

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 65862-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetronod-fig1 (Ondansetronod Fig1)

Ondansetron Orally Disintegrating Tablets USP 4 mg label from Aurobindo Pharma Limited. The label states the product is prescription only and contains 30 tablets. It includes storage instructions, phenylalanine content warning, distributor info, and advises dispensing in a tight, light-resistant container. Barcode and product code are visible.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

Ondansetron Orally Disintegrating Tablets USP 4 mg packaging label by Aurobindo Pharma Limited. The label indicates a package of 30 tablets (3 blister cards with 10 tablets each). It includes storage instructions, child-resistant packaging info, and dispensing precautions. Distributor information lists Aurobindo Pharma USA, Inc., East Windsor, NJ. The label features usage instructions with illustrations on how to administer the orally disintegrating tablets.*

FDA Label Image

Package Label-principal Display Panel (8 mg (6,000 Tablets Bottle))

Ondansetron Orally Disintegrating Tablets, USP 8 mg label from Aurobindo Pharma Limited. The label states each tablet contains 8 mg Ondansetron USP and includes phenylketonurics warning for phenylalanine content. It specifies storage conditions, dosage directions reference package insert, and packaging of 30 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

Packaging label for Ondansetron Orally Disintegrating Tablets, USP 8 mg by Aurobindo Pharma Limited. The label states Rx only and includes the quantity of 30 tablets (3 blister cards each with 10 tablets). It shows dosage information, storage instructions, child-resistant packaging note, and illustrates how to remove tablets from the blister pack. Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, showing its molecular framework including a ketone group, methyl substitutions, and a heterocyclic ring system consistent with its known formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.